A High Resolution Autopsy Study Evaluating the Relationship of 18F-AV-1451 PET Imaging and Tau Pathology
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 28 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Mar 2018.
- 28 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Mar 2018.
- 11 Oct 2017 Status changed from recruiting to active, no longer recruiting.